https://www.prnewswire.com/news-releases/primary-endpoint-achieved-in-cavatak-phase-2-melanoma-trial-224211551.html
/PRNewswire/ -- Viralytics Limited (ASX: VLA, OTCQX: VRACY) has achieved the primary endpoint in its Phase 2 clinical trial of CAVATAKTM in the treatment of...
primary endpointachievedcavatakphasemelanoma
https://www.fda.gov/about-fda/division-patient-centered-development/clinician-reported-outcomes-co-primary-endpoint-stroke-treatment-device
Use of UW-mRS along with a more traditional ClinRO can be used to validate this new ClinRO as it is used in clinical studies of acute ischemic stroke therapies.
in coprimary endpointclinicianreportedoutcomes
https://www.medicaldevice-developments.com/news/gores-venous-stent-study-meets-primary-endpoint/
Nov 10, 2025 - W. L. Gore & Associates’ medical division has reported that a study of the GORE VIABAHN FORTEGRA Venous Stent met its primary endpoint.
primary endpointvenousstentstudymeets
https://www.news-medical.net/news/20150812/AbbVies-venetoclax-Phase-2-trial-meets-primary-endpoint-in-patients-with-relapsedrefractory-CLL-with-17P-deletion.aspx
AbbVie, a global biopharmaceutical company, today announced that a Phase 2 trial of its investigational medicine venetoclax met its primary endpoint of...
primary endpointabbvievenetoclaxphasetrial